2. Academic Validation
  3. 3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)

3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)

  • Bioorg Med Chem Lett. 2012 Jul 15;22(14):4654-9. doi: 10.1016/j.bmcl.2012.05.116.
John T-A Hsu 1,  Teng-Kuang Yeh,  Shih-Chieh Yen,  Chiung-Tong Chen,  Shu-Yi Hsieh,  Tsu Hsu,  Cheng-Tai Lu,  Chun-Hwa Chen,  Ling-Hui Chou,  Ching-Hui Chiu,  Yun-I Chang,  Ya-Ju Tseng,  Kuei-Rong Yen,  Yu-Sheng Chao,  Wen-Hsing Lin,  Weir-Torn Jiaang
Affiliations

Affiliation

  • 1 Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, No. 35, Keyan Rd., Zhunan Town, Miaoli Country 350, Taiwan, ROC.
PMID: 22726931 DOI: 10.1016/j.bmcl.2012.05.116
Abstract

A new class of FLT3 inhibitors has been identified based on the 3-phenyl-1H-5-pyrazolylamine scaffold. The structure-activity relationships led to the discovery of two carbamate series, and some potent compounds within these two series exhibited better growth inhibition of FLT3-mutated MOLM-13 cells than FLT3 inhibitors sorafenib (2) and ABT-869 (3). In particular, compound 8d exhibited the ability to regress tumors in mouse xenograft model using MOLM-13 cells.

Figures
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z